<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01315821</url>
  </required_header>
  <id_info>
    <org_study_id>1234</org_study_id>
    <nct_id>NCT01315821</nct_id>
  </id_info>
  <brief_title>Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants</brief_title>
  <official_title>Role Of Saccharomyces Boulardii in Preventin Necrotizing Enterocolitis in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal
      system and stimulate the immune system. Necrotizing enterocolitis incidence is 10-25% in
      newborn infants whose birth weights are &lt; 1500 gr. Although bifidobacterium and lactobacilli
      sp. have been used to reduce the incidence of NEC in clinical trials, Saccharomyces boulardii
      has not been used in the prevention of NEC in very low birth weight infants yet. The
      objective of this study is to evaluate the efficacy of orally administered S boulardii in
      reducing the incidence and severity of NEC in very low birth weight infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary outcome of this study is to evaluate the efficacy of orally administered S
      boulardii in reducing the incidence and severity of NEC in very low birth weight infants.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Saccharomyces boulardii on necrotizing enterocolitis in VLBW infants</measure>
    <time_frame>up to 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Saccharomyces boulardii on culture proved sepsis</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Saccharomyces boulardii on weight gain</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Saccharomyces boulardii on length of hospital stay</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Saccharomyces boulardii on mortality</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <condition>Very Low Birth Weight Infants</condition>
  <arm_group>
    <arm_group_label>Saccharomyces boulardii</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Saccharomyces boulardii 5 million unit/day for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo- for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saccharomyces boulardii</intervention_name>
    <description>5 million units/day for 3 months</description>
    <arm_group_label>Saccharomyces boulardii</arm_group_label>
    <other_name>Reflor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for 3 months</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Very low birth weight infants &lt; 1500 gr

        Exclusion Criteria:

          -  Genetic anomalies

          -  Not willing to participate

          -  Allergy to S. boulardii components
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gamze Demirel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gamze Demirel, MD</last_name>
    <phone>+903123065270</phone>
    <email>kgamze@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ugur Dilmen</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gamze Demirel</last_name>
    </contact>
    <investigator>
      <last_name>Gamze Demirel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2011</study_first_posted>
  <last_update_submitted>August 4, 2011</last_update_submitted>
  <last_update_submitted_qc>August 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>Zekai Tahir Burak Maternity Teaching Hospital</name_title>
    <organization>Zekai Tahir Burak Maternity Teaching Hospital</organization>
  </responsible_party>
  <keyword>Saccharomyces boulardii</keyword>
  <keyword>necrotizing enterocolitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

